Osteoporosis Treatment Market Size - By Drug Class (Hormone Replacement Therapy, Bisphosphonate, RANK ligand Inhibitor, Selective Estrogen Receptor Modulator, Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies & Stores, Others) and By Region: Global & Forecast, 2024-2033

  • 2023-12-13
  • 204
  • Healthcare & Life Sciences

Market Overview

Osteoporosis Treatment Market Size is projected to achieve a value of USD 12.21 Billion in 2023, with a linear behavior in the market growth it is forecasted to achieve a value of USD 19.65 Billion by 2033 with a CAGR of 4.5% during the forecast period 2024-2033.

Osteoporosis treatment primarily focuses on strengthening bones, minimizing bone loss, and preventing fractures. It often involves a combination of lifestyle changes, dietary adjustments, and medications. Weight-bearing exercises and resistance training help improve bone density, while calcium and vitamin D supplements aid in bone health. Medications such as bisphosphonates, hormone therapy, or monoclonal antibodies may be prescribed to prevent further bone weakening. Regular screenings and discussions with healthcare providers assist in personalized treatment plans, aiming to mitigate the risk of fractures and enhance overall bone strength.

SOURCE: We Market Research

The global market for therapies for osteoporosis is influenced by various factors. The aging population worldwide is a major factor propelling market rise, especially in developed nations where osteoporosis is more prevalent in the elderly. New methods of early detection and effective management, along with technical advancements in therapy and diagnostics, are driving market expansion. Market demand is also influenced by government initiatives that promote bone health and preventative care, as well as expanding awareness efforts. In addition, the market is being driven by the increasing need for innovative medications and treatment choices to address this worldwide health concern as osteoporosis-related fractures become more prevalent.

Market Scope

Report Attributes


Market Size in 2023

USD 12.21 Billion

Market Forecast in 2033

USD 19.65 Billion

CAGR % 2024-2033


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Drug Class, By Route of Administration ,By Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

Osteoporosis Treatment Industry: Dynamics & Restrains

Market Drivers

Rising Healthcare Expenditure - The market for osteoporosis treatments is driven by rising healthcare costs since these costs are being allocated to more research, cutting-edge treatments, and diagnostic equipment. The availability of osteoporosis therapeutics is improved as a result of increased funding for cutting-edge medications, individualized therapy, and effective healthcare delivery systems brought about by rising healthcare spending. This increase in funding encourages the development of new drugs and improves healthcare infrastructures, which in turn leads to improved osteoporosis treatment options and diagnostic tools. As a result, there is an increase in demand in the market, which propels development and progress in treating this bone health issue.

Increasing Aging Population - The market for osteoporosis treatments is driven by the aging population since age is still a major risk factor for osteoporosis. Osteoporosis is becoming more common as the number of older people in the population grows, which increases the need for both prevention and therapeutic interventions. This shift in the population is responsible for pharmaceutical research, treatment innovation, and healthcare programs designed to specifically meet the demands of aging populations. In addition, a greater emphasis on early detection and intervention due to growing awareness of the problems with bone health that older people confront is driving the market for osteoporosis treatments.

Market Restrains

Side Effects of Treatment - The market for osteoporosis medicines may be constrained by the adverse effects of those treatments, which may have an impact on patient acceptance and adherence. Adverse effects, such as gastrointestinal problems, musculoskeletal pain, or infrequent but serious consequences, can occur from several osteoporosis drugs. These adverse effects frequently cause patients to become reluctant or stop taking their medications, which has an effect on the market as patients choose non-pharmacological methods or healthcare practitioners look for other therapy. In order to mitigate these market constraints, research and development efforts aimed at minimizing adverse responses and enhancing treatment compliance are encouraged by the concern over side effects, which highlights the need for safer, more bearable treatment options.

Osteoporosis Treatment Segmentation

Market- By Drug Class Analysis

By Drug Class, the Osteoporosis Treatment Market is Categories into Hormone Replacement Therapy, Bisphosphonate, RANK ligand Inhibitor, Selective Estrogen Receptor Modulator, Others. The Bisphosphonate segment accounts for the largest share of around 43% in 2022.

A popular class of medications known for slowing down bone loss and lowering the risk of fractures are called bisphosphonates. Their demonstrated effectiveness, affordability, and simplicity of use are the main factors propelling this market. However, uncommon but dangerous adverse effects such atypical femur fractures and jaw osteonecrosis may be linked to prolonged use.

The following segments are part of an in-depth analysis of the global Osteoporosis Treatment Market:

Market Segments


By Route of Administration

·         Oral

·         Parenteral

By Distribution Channel

·         Hospitals Pharmacies

·         Retail Pharmacies & Stores

·         Others

Osteoporosis Treatment Industry: Regional Analysis

North America Market Forecast

North America dominate the Osteoporosis Treatment Market with the highest revenue generating market with share of more than 44%. Osteoporosis is more common in North America due in large part to the country's aging population. Osteoporosis is more common as people get older, which raises the need for therapy. Additionally, a greater market for osteoporosis therapy exists in this region due to early diagnosis, increasing knowledge of the disease, and access to state-of-the-art medical facilities.

Europe Market Statistics

Europe is the second-largest market for Osteoporosis Treatment. Osteoporosis diagnosis and treatment are being improved by a number of government efforts and healthcare policies, which is driving market expansion. Additionally, developed healthcare systems in nations like the UK, Germany, and France provide improved access to diagnosis and treatment, which supports market growth.

APAC Market Forecasts

Asia Pacific is expected to be the fastest-growing market for Osteoporosis Treatment during the forecast period. Osteoporosis rates are rising in the region due to urbanization and changing lifestyles, which is driving up demand for therapies. Other factors driving this trend include dietary changes and decreased physical activity. Additionally, rising healthcare costs and easier access to healthcare, especially in developing nations like China and India, support market expansion.

Competitive Analysis

The Osteoporosis Treatment Market is dominated by a few large companies, such as

·         Novartis International AG

·         Mylan N.V.

·         Gilead Sciences, Inc.

·         Merck & Co., Inc.

·         F. Hoffmann-La Roche Ltd.

·         Takeda Pharmaceutical Company Limited

·         Eli Lilly and Company

·         Pfizer Inc.

·         AbbVie Inc.

·         Sanofi

·         Johnson & Johnson

·         Sun Pharmaceutical Industries Ltd.

·         GlaxoSmithKline PLC

There are some of the key trends that are shaping the competitive landscape of the Osteoporosis Treatment Market.

·         August 2021, The Drug Controller General of India (DCGI) granted Enzene Biosciences Ltd. Marketing Authorization (MA) for denosumab, a biosimilar medication used to treat osteoporosis in adults.

·         August 2019, Terrosa, a biosimilar teriparatide, was introduced into the European market by GEDEON Richter after the patent for the reference drug expired. This medicine is intended to treat two conditions: osteoporosis in postmenopausal women and men with a high fracture risk, and osteoporosis associated with extended systemic glucocorticoid therapy in women and men at high fracture risk.

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Osteoporosis Treatment Market in 2022?

Osteoporosis Treatment Market was valued at USD 11.13 Billion in 2022.

What is the growth rate for the Osteoporosis Treatment Market?

Osteoporosis Treatment Market size will increase at approximate CAGR of 4.5% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Osteoporosis Treatment Market are Novartis International AG, Mylan N.V., Gilead Sciences, Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Pfizer Inc., AbbVie Inc., Sanofi, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC and Other.

Which region dominates the Osteoporosis Treatment Market?

North America dominates the market with an active share of 44%.


Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI